CC BY 4.0 · The Arab Journal of Interventional Radiology 2023; 07(S 01): S1-S41
DOI: 10.1055/s-0043-1763302
Category: Vascular Interventions

Aspiration Thrombectomy with the Indigo System for Acute Lower Limb Ischemia: Our Experience

Ronconi Edoardo
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Marcello Andrea Tipaldi
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Quarta Colosso Giulio
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Bozzi Fernando
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Giuseppe Tremamunno
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Giovanna Bona
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Siciliano Francesco
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Aleksejis Zolovkins
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Gianluigi Orgera
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
,
Michele Rossi
1   Ospedale Sant'Andrea La Sapienza Università Di Roma, Roma, Italy
› Author Affiliations
 

Introduction: To assess the short-term technical success and the safety of the IS in a series of patients undergoing vacuum-assisted catheter direct thrombus aspiration (IS-CDTA) for acute lower limb ischemia (ALLI) and to analyze which parameters may affect the outcome.

Method(s): All procedures using the IS-CDTA for ALLI performed in a single center interventional radiology unit from February 2016 to March 2020 were analyzed retrospectively. Technical success was defined as the achievement of nearly-complete or complete revascularization (TIMI grade 2/3) and was considered as a good outcome. Variables potentially correlated with the IS-CDTA outcome were analyzed.

Result(s): A total of 33 procedures were performed in 29 patients. The technical success was 70%. The median time between symptom insurgency and IS-CDTA was significantly shorter in patients with good IS-CDTA outcome (10 hours; IQR 2.75–48) compared with those with poor IS-CDTA outcome (168 hours; IQR 36–336), p = 0.003.

Conclusion(s): IS-CDTA is a valid option for a rapid and percutaneous treatment of ALLI. The time elapsing from the symptom insurgency and the endovascular procedure is the best positive predictor of success.



Publication History

Article published online:
09 February 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India